What is Krystal Biotech, Inc. Common Stock's Market Cap?

Krystal Biotech, Inc. Common Stock's Market Cap is $10.4B, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Enterprise Value?

Krystal Biotech, Inc. Common Stock's Enterprise Value is $10.0B, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Trailing P/E?

Krystal Biotech, Inc. Common Stock's Trailing P/E is 43.1×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Price / Sales?

Krystal Biotech, Inc. Common Stock's Price / Sales is 23.6×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's EV / Revenue?

Krystal Biotech, Inc. Common Stock's EV / Revenue is 22.6×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's EV / EBITDA?

Krystal Biotech, Inc. Common Stock's EV / EBITDA is 50.0×, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Revenue (TTM)?

Krystal Biotech, Inc. Common Stock's Revenue (TTM) is $440.5M, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Net Income (TTM)?

Krystal Biotech, Inc. Common Stock's Net Income (TTM) is $241.5M, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's EBITDA?

Krystal Biotech, Inc. Common Stock's EBITDA is $203.6M, based on as-reported figures from SEC (XBRL) filings.

What is Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM)?

Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM) is 8.16, based on as-reported figures from SEC (XBRL) filings.

Krystal Biotech, Inc. Common Stock (KRYS) Financial Statements

Krystal Biotech, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00HDGRHJ5

XNAS · usd

351.26▼ 6.98 (-1.95%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close358.24

Day's Range343.46 – 354.69

52-Week Range136.73 – 382.54

Volume255.6K

Avg Volume281.0K

Share Statistics

Shares Outstanding

Employees295

ExchangeXNAS

Listed2017-09-20

Share count as of July 28, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Krystal Biotech, Inc. Common Stock (KRYS)

What is Krystal Biotech, Inc. Common Stock's Market Cap?: Krystal Biotech, Inc. Common Stock's Market Cap is $10.4B, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Enterprise Value?: Krystal Biotech, Inc. Common Stock's Enterprise Value is $10.0B, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Trailing P/E?: Krystal Biotech, Inc. Common Stock's Trailing P/E is 43.1×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Price / Sales?: Krystal Biotech, Inc. Common Stock's Price / Sales is 23.6×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's EV / Revenue?: Krystal Biotech, Inc. Common Stock's EV / Revenue is 22.6×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's EV / EBITDA?: Krystal Biotech, Inc. Common Stock's EV / EBITDA is 50.0×, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Revenue (TTM)?: Krystal Biotech, Inc. Common Stock's Revenue (TTM) is $440.5M, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Net Income (TTM)?: Krystal Biotech, Inc. Common Stock's Net Income (TTM) is $241.5M, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's EBITDA?: Krystal Biotech, Inc. Common Stock's EBITDA is $203.6M, based on as-reported figures from SEC (XBRL) filings.
What is Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM)?: Krystal Biotech, Inc. Common Stock's Diluted EPS (TTM) is 8.16, based on as-reported figures from SEC (XBRL) filings.